Medtronic has raised $1 billion in a sale of new corporate debt, The Wall Street Journal reports. The biomedical device company has split the deal evenly, with $500 million in each tranche.
The five-year notes were sold with a 2.625% coupon, while the 10 year debt has a coupon rate of 4.125%. Bank of America Merrill Lynch, Citigroup and RBS were the joint book-running managers for the sale.
Click here for the story from The Wall Street Journal.